Skip to content

DEXAMED

Active
Private limited companyfounded 2007active for 19 yearsBlauwhuisstraat 26, 8020 Oostkamp, BelgiumKBO/BCE: BE 0886.182.892

Acts, filings and financial milestones

Deadline for the 2026 accounts: 31-01-2027
2026
16-07
Gazette deed Appointment: Hilde Focke (director)
Resignation: Xavier Deklerck (director)3 points ▸
  • General meeting, 08-07-2026
  • Director appointment, Hilde Focke (director)
  • Director resignation, Xavier Deklerck (director)

Open the act in the Belgian Official Gazette

2025
23-12
NBB filing Annual accounts filedPDF
financial year 2025 · micro format
30-06
Financial Back to profitnet €11,008
The net result is €11,008, after 2 loss-making years.
2024
18-11
NBB filing Annual accounts filedPDF
financial year 2024 · micro format
08-01
NBB filing Annual accounts filedPDF
financial year 2023 · micro format
2023
18-10
Gazette deed Resignation: Xavier Deklerck (manager and director)
Appointments: Xavier Deklerck (director) and Hilde Focke (opvolgend niet statutair bestuurder) · Capital conversion · Amendment of the articles12 points ▸
  • General meeting, 13-10-2023
  • Other provision, “aanpassing statuten aan WVV met behoud rechtsvorm, statuten aanpassen aan Wetboek van vennootschappen en verenigingen” (deed in Dutch)
  • Capital conversion, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
  • Amendment of the articles, 2
  • Amendment of the articles
  • Capital
  • Director resignation, Xavier Deklerck (manager and director)
  • Director discharge, Xavier Deklerck
  • Director appointment, Xavier Deklerck (director)
  • Other provision, “verbodsverklaring, uitoefening niet verboden inzonderheid KB nr 22 van 1934-10-24” (deed in Dutch)
  • Director appointment, Hilde Focke (opvolgend niet statutair bestuurder)
  • Other provision, “kennisname opvolgende benoeming en bekwaamheidsbevestiging” (deed in Dutch)

Open the act in the Belgian Official Gazette

30-06
Financial Weakest financial yearnet -€85,618
The net result drops to -€85,618, the lowest from 2019 to 2025. It recovers the following year.
2022
14-12
NBB filing Annual accounts filedPDF
financial year 2022 · micro format
30-06
Financial Highest result from 2019 to 2025net €25,865 ▲94.8%
The operating result of €54,952 and the net result of €25,865 are both a record.
30-06
Financial Equity above €500,000equity €520,738 ▲4.9%
With a profit in every financial year since 2019, equity grows to €520,738.
14-01
NBB filing Annual accounts filedPDF
financial year 2021 · micro format
2020
16-12
NBB filing Annual accounts filedPDF
financial year 2020 · micro format
Show earlier events
30-06
Financial Liquidity more than doubledcurrent ratio 10.64
The current ratio rises from 3.71 to 10.64. Short-term debt falls from €89,383 to €47,516.
18-02
NBB filing Annual accounts filedPDF
financial year 2019 · micro format · 18 days late
2019
28-02
NBB filing Annual accounts filedPDF
financial year 2018 · micro format · 28 days late
2018
27-02
NBB filing Annual accounts filedPDF
financial year 2017 · micro format · 27 days late
2017
13-01
NBB filing Annual accounts filedPDF
financial year 2016 · abbreviated format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

On 8 January 2007, DEXAMED was incorporated.1 Total assets went from €972,726 in 2019 to €566,313 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2019 and 2025

Next steps